SARS CoV-2 Phase Four SOP

This SOP proposal has been written on behalf of the IOMDA after careful analysis of several countries around the world where National and Regional Governments and professional organisations had published recommendations or guidance for the re-opening of dental services during the SARS CoV- 2 Pandemic. Thank you to the colleagues of the IOMDA that have assisted in the formulation of this proposal for the Isle of Man.

Page of 1 25

Contents

1. Introduction and Current Position - Phase Three..…….3

2. Background on measures taken by other jurisdictions…5

3. Background on Sars-Cov 2 and Covid-19……………….6

4. Phase Four: Reopening of dental practices with no

l i m i t a t i o n s t o t h e l e v e l o f s e r v i c e

provided……………………………………….…………10

5. Miscellaneous……………………………………………14

6. Precautions in case of a second peak………………..…15

7. References and bibliography………………………..…15

8. Appendices - Procedures for Infection Prevention and

control………………………………………………….…….20

Page of 2 25

1. Introduction and Current Position - Phase Three

This Operational Plan is to propose some suggestions about the Phase Three

approach related to the provision of dentistry on the Isle of Man as a result of

the SARS-CoV-2 pandemic in the 2020. The evidence base on COVID-19 is

rapidly evolving and further updates may be made to this document as new

detail or evidence emerges.

A paucity of robust scientific research has led to further differing opinion as to

the most appropriate pathways and procedures to enable dentistry to be

completed in a safe environment for both patients and operators.

Emergency dental care for the populace of the Isle of Man has been provided

in terms of advice, analgesia and antimicrobial prescription with direct

treatment for life threatening conditions (typically tooth extractions) from a

central location since 27 March 2020. This followed the directed closure of all

dental practices.

Due to the relatively low number of Covid-19 cases, the Island has been in a

position to supersede the care provision in the United Kingdom. Guidance

from jurisdictions in nearby countries, from which the Island would normally

take direction (e.g. England) could soon be considered insufficiently advanced

for the Island’s position.

The Isle of Man dental service has been subsequently allowed to operate on

Phase Two. A second practice has been used by the Department of Health for

Page of 3 25

the delivery of the services previously being delivered solely at CDS. This

decision has been taken in order to create more capacity. This practice

(Hillside) is a government-owned property, managed by one of the General

Dental Service (GDS) Dental Providers. It is also within the same site as the

CDS. This service has been running since 20 May 2020.

CDS changed its remit and commenced more extensive treatments for patients

via referral from General Dental Practitioners (GDPs). This required a

relaxation on the suspension of AGPs at the CDS and allowed CDS to be the

focus for Level 3 PPE.

This phase has seen the provision of Urgent Dental Care split into 2 pathways:

• Tier 1 – GDP Triage and Referral Service

Management of all patients through remote triage , providing advice,

prescription of analgesia and antimicrobials, non-AGP treatments and

appropriate referrals for treatment.

• Tier 2 – CDS Referral and Treatment Service

Working on a referral only basis; receiving patients and delivering treatments

as required with the use of AGPs.

Since 4 June 2020 the Island dental service is operating on Phase Three which

has seen the level of services provided being limited to Essential treatments

and the highest level of PPE and precautions.

Due to the present situation the Isle of Man finds itself in, with a no or

extremely low level of transmission of SARS CoV-2 the island is able to

proceed to the next phase in the provision of dentistry to the island population.

Page of 4 25

This next phase will see the retention of most precautions derived from the

previous SOP with a relaxation of the level of PPE and resumption of all

services.

Information from pan-global countries whose Covid-19 situation is projected

to be akin to the Island’s has been considered, as well as information from the

United Kingdom, in the production of this document.

This document has been produced to support Dental Professionals on the Isle

of Man so that they can safely work using different protocols to those currently

in place. This will allow dental practices on the Island to re-open and treat

patients in a way that best supports the Isle of Man Government’s phased

response to the current COVID-19 situation, until the next phase can be

justified and implemented.

Consistency in adopting the recommended actions will ensure the safety of

patients, staff and the population, while maintaining access to quality

healthcare for members of the public on the Isle of Man. 1

2. Background on measures taken by other jurisdictions

The World Health Organisation (WHO) declared the coronavirus disease

(COVID-19) outbreak as a public health emergency of international concern on

the 30 January 2020 and a global pandemic on the 11 March 2020.

Page of 5 25

COVID-19 spreads primarily through droplets and fomites. The close working

environment and the potential for aerosol spread of the virus through dental

procedures, such as use of high and low-speed handpieces, ultra-sonic scalers,

air/water syringes, intra-oral radiographs or an infected patient coughing,

places dental health workers at an elevated risk of infection.

Pandemic planning for dental services typically involved a step-down process,

with the cancellation of routine care first, then urgent care followed by the

provision of emergency care only. In many countries, the move to emergency

care provision was rapid. For example, on the 16 March 2020 the American

Dental Association proposed that dentists defer all elective dental care for 3

weeks; in Scotland, Wales and Northern Ireland, all aerosol generating

practices were stopped on the 17 March and practitioners were told to stop all

routine face-to-face dentistry on the 23 March. On the same day in New

Zealand, all non-essential and elective dental treatment was suspended. By the

end of April 2020, National and Regional Governments and professional

organisations had published recommendations or guidance for the re-opening/

re-structuring of dental services. 2

3. Background on Sars-Cov 2 and Covid-19

Coronavirus disease (COVID-19) is an infectious disease caused by a newly

discovered Coronavirus, seventh member of the Coronaviridae family,

identified with the name SARS CoV-2. The new virus began spreading at the

Page of 6 25

end of December 2019 in the Chinese territory of Wuhan (Zhu N et al., 2020 3:

Wang C et al., 2020 4)

The transmission of COVID-19 is thought to occur mainly through respiratory

droplets generated by coughing and sneezing, and through contact with

contaminated surfaces (To K et al., 20205; Rodriguez-Morales AJ et al., 20206).

The predominant modes of transmission are assumed to be droplet and contact.

This is consistent with a recent review of modes of transmission of COVID-19

by the World Health Organization (WHO).

SARS CoV-2 has shown a high transmission rate potential. The R0 has been

estimated by WHO to be between 2.5 and 3. This means, without any form of

measure to limit the spread of the virus and to protect the public and

healthcare workers from the possibility of infection, 1 individual infected is

likely to infect between 2 and 3 people.

The incubation period for the infected individuals is ranging from 1 to 14 days.

However, some cases reported rare cases of incubation periods of 24 days. It

has also been confirmed that asymptomatic patients can transmit the virus.

(Huang C et al., 2020 7; Guan WJ et al., 2020 8; Backer Ja et al., 2020 9)

The most common symptoms of coronavirus (COVID-19) are recent onset of

new continuous cough and/or high temperature

From international data, the balance of evidence is that infectivity has

significantly reduced seven days after the onset of symptoms.

Page of 7 25

COVID-19 for most individuals causes mild to moderate illness, but it may

result in pneumonia or severe acute respiratory infection (ARDS) (Huang C et

al., 2020 7; Liu T et al. 2020 12).

The median time from symptom onset to clinical recovery:

- mild cases - 2 weeks

- severe or critical cases - 3-6 weeks

It has been demonstrated using Real Time PCR, how vital viruses where

present in the saliva of the infected individuals (To K et al., 2020 10; Lescure

FX et al.11). It has been also shown SARS CoV-2 enters the cells like SARS

CoV, through the ACE2 receptors. (De wit et al., 201613)

The ACE2+ cells are abundant in the upper respiratory tract and in the

epithelium of the ducts of the salivary glands (Belouzard S et al., 201214 ; Liu

et al. 2020 17).

The current national approach is to ensure that social distancing measures are

observed to reduce social interaction between people in order to reduce the

transmission of coronavirus (COVID-19).

Stringent social distancing measures are required for those in vulnerable and

shielded population groups.

The most common symptoms of coronavirus (COVID-19) are the recent onset

of new continuous cough and/or high temperature.

Page of 8 25

From international data, the balance of evidence is that infectivity has

significantly reduced seven days after the onset of symptoms.

Those with symptoms of coronavirus illness (COVID-19), however mild, need

to stay at home for seven days from when their symptoms started. Any

household members who remain well must stay at home and not leave the

house for 14 days. The 14-day period starts from the day when the first person

in the house became ill.

Human coronaviruses can survive on inanimate objects and in the air. The new

coronavirus seems to remain viable for up to 3 hours in the air in an ideal,

static, non ventilated environment and for several hours on different materials

like stainless steel, copper, cardboard and plastic (Kampf G et al., 202015 Van

Doremalen N et al., 2020 18)

Interrupting transmission of COVID-19 requires contact, droplet and aerosol

precautions depending on procedures undertaken.

Frequent hand washing for 20 seconds is central to preventing and delaying the

spread of SARS CoV-2 through contact.

Social distancing measures have been introduced worldwide to reduce the

droplet transmission.

Aerosol transmission of the disease needs more data to be confirmed, however,

datas from previous coronaviruses suggests it is likely and it is therefore

Page of 9 25

suggested to take all possible measures and precautions to interrupt this

possible transmission pathway.

During Aerosol Generating Procedures (AGPs), there is an increased risk of

aerosol spread of infectious agents irrespective of the mode of transmission

(Peng X et al., 202016), and airborne precautions must be implemented when

performing AGPs, including those carried out on a possible or confirmed case

of COVID-19.

Every patient should be treated as a potential carrier.

4. Phase Four: Reopening of dental practices with no limitations

to the levels of service provided.

I: Pre-clinical (Meng L et al., 202019; Cochrane Oral Health 2)

A. Patient Triage over the phone

B. Suspected Covid positive cases will be suggested to call 111.

C. Staff training

D. Assessment of the risk profile of patients and staff.

E. The diary organisation should reflect the need to comply with social distancing

rules, the possibility of needing AGPs and patient risk profile (for example

shielded patients at the beginning of the day)

F. No walk in patients, only pre-arranged appointments after triage.

Page of 10 25

G. Patients should be informed about the relevant changes and precautions in

place before attending the appointment

II: Reception/Waiting area. (Cochrane Oral Health 2; Meng L et al., 202019;

WHO 202020; Yang Y et al.21, 2020; CDC 202022; Ma QX et al., 202024 Liu Y

et al 35 ; Fong MW et al., 2020 36;)

A. Repeat in office triage

B. Alcohol hand rub on entrance.

C. Body Temperature taken on arrival at the dental clinic, if possible using

contactless thermometer. If this is elevated, over 37.8, patient will be excluded

from treatment.

D. The number of people in the waiting/reception area needs to be reduced to the

minimum possible. Strict social distancing rules in place. Preferably patients

will attend on their own unless they are under aged children or vulnerable/

disabled patients in need of a guardian/carer. Patients can wait in their car and

can then be called or messaged to enter the practice if social distancing cannot

be maintained. Patients will be asked to leave personal belongings, scarf, coat

etc in the car (or at home) if possible.

E. Pens need to be disinfected or ideally brought in by the patient.

F. Remove unnecessary objects (ie magazines)

G. Sneezing shields at reception are advised.

Page of 11 25

H. Reception staff to wear surgical masks and eye protection if social distancing

cannot be maintained.

I. All forms are to be signed at reception.

J. Guidance in place for patient to avoid toilets, if toilet use is inevitable, it needs

to be disinfected after its use. Hand rub at its entrance.

K. Lists of people entering building need to be kept in case contact tracing

needed.

L. Cashless and contactless payments if possible.

M. Non clinical areas to be cleaned and disinfected at least three times a day.

III: Clinical/Surgical area (Cochrane Oral Health 2; ECDC 2020 26; Meng L

et al., 202019; WHO 202020; Yang Y et al.21, 2020; CDC 202022; Bartoszko JJ et

al., 202023; Ma QX et al., 202024 ; Leung NH et al., 202025 ; Peng X et al.,

201916)

A. Training needed on the correct procedure followed by clinicians when walking

in the clinic re clothes, uniform, changing room, donning and doffing.

B. Remove unnecessary objects, pieces of equipment, furniture.

Page of 12 25

C. PPE on clinical area and clinical staff:

For all procedures a minimum of: non-sterile gloves, fluid resistant surgical

mask, eye protection (Safety glasses that have side vents; or goggles; or

prescription glasses covered with a full face shield/visor) disinfected after

every patient and apron (single use) for no/low AGP or long sleeve impervious

gowns (AGP), is recommended. (Bartoszko JJ et al., 202023; Ma QX et al.,

202024 ; Leung NH et al., 202025, WHO 202020)

IV: Disinfection and decontamination of surfaces in all areas. (Kampf G et

al 202015)

It is recommended to use approved disinfectants for medical-dental use for

large surfaces, Alcohol (over 70%) for small surfaces.

V: Post clinical (WHO 202020; CDC 202037; ECDC26 )

A. Safe protocols on doffing and how to leave the workplace need to be followed.

B. After the appointment, the patient should walk out of the clinic as soon as

possible.

VI: Patient protection from the dental team

Page of 13 25

A. Dental teams to be swab tested for COVID-19 twice monthly if possible

B. Surgical masks need to be warn on top of filtrating masks when valves are

present.

VII: Dental Laboratories

In relaxing the restrictions on dental practices it is suggested that the

restrictions also lift to enable dental laboratories to re-open and receive

referrals from dental practices. In Phase Four all services can resume.

Strict Guidance on disinfection of impressions and appliances needs to be

followed.

5. Miscellaneous

A. Practice will provide services during normal operating hours.

B. Emergency rota during weekends continues as per arrangements prior the

directed closure.

C. Patient will be able to attend to their regular/registered practice. Unregistered

patients will continue to be seen by CDS.

D. All measures will be subject to fortnightly review.

Page of 14 25

6. Precautions in case of a second peak.

A. Practices and practice groups need to still meet the Quality Assurance

requirements needed to operate under the current SOP.

B. Practices and practice groups need to operate for a minimum period of two

weeks with the higher level of restrictions in the surgical/clinical area present

in the Phase Three SOP before being able to operate with the Phase Four

SOP.

C. In case of a second wave the level of precautions currently needed in the

surgical/clinical area will resume in accordance to the IOM SOP Phase 3

Section 4, Paragraph III.

7. References and bibliography

1 SOP UDC (Isle of Man) V1 28-4-20

2 Recommendations for the re-opening of dental services: a rapid review of international sources V 1.1 7-5-20 Cochrane Oral Health.

3 Zhu N et al. A novel coronavirus from patients with pneumonia in China, 2019. N. Engl. J. Med. https://doi.org/10.1056/NEJMoa2001017 (2020).

4 Wang C, Horby PW, Hayden FG & Gao GF. A novel coronavirus outbreak of global health concern. Lancet 395, 470–473 (2020);

Page of 15 25

5 To K, KW. et al. Consistent detection of 2019 novel coronavirus in saliva. Clin. Infect. Diseases https://doi.org/10.1093/cid/ciaa149 (2020);

6 Rodriguez-Morales AJ, MacGregor K, Kanagarajah S, Patel D & Schlagenhauf, P. Going global - Travel and the 2019 novel coronavirus. Travel. Med. Infect. Dis. 101578, https://doi.org/10.1016/j.tmaid.2020.101578 (2020);

7 Huang, C. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395, 497–506 (2020);

8 Guan Wj et al. Clinical characteristics of 2019 novel coronavirus infection in China. Preprint at https://www.medrxiv.org/content/10.1101/2020.02.06.20020974v1 (2020);

9 Backer J A, Klinkenberg D. & Wallinga J. Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20–28 January 2020. Euro. Surveill. https://doi.org 10.2807/1560-7917.Es.2020.25.5.2000062 (2020);

10 To K, KW. et al. Consistent detection of 2019 novel coronavirus in saliva. Clin. Infect. Diseases https://doi.org/10.1093/cid/ciaa149 (2020);

11 Lescure FX, Bouadma L, Nguyen D et al. Clinical and virological data of the first cases of COVID-19 in Europe: a case series. Lancet Infect Dis. 2020 Mar 27. pii: S1473- 3099(20)30200-0. doi: 10.1016/S1473-3099(20)30200-0. [Epub ahead of print (2020);

12 Liu T et al. Transmission dynamics of 2019 novel coronavirus (2019-nCoV). The Lancet. Available at SSRN: https://ssrn.com/abstract=3526307 (2020);

13 De Wit E, van Doremalen N, Falzarano D & Munster VJ. SARS and MERS: recent insights into emerging coronaviruses. Nat. Rev. Microbiol. 14, 523–534 (2016);

Page of 16 25

14 Belouzard S, Millet JK, Licitra BN & Whittaker GR. Mechanisms of coronavirus cell entry mediated by the viral spike protein. Viruses 4, 1011–1033 (2012);

15 Kampf G, Todt D, Pfaender S & Steinmann E. Persistence of coronaviruses on inanimate surfaces and its inactivation with biocidal agents. J. Hosp. Infect. https://doi.org/10.1016/j.jhin.2020.01.022 (2020);

16 Peng X, Xu X, Li Y, Cheng L, Zhou X, Ren B. Transmission routes of 2019-nCoV and controls in dental practice. Int J Oral Sci. 2020 Mar 3;12(1):9. doi: 10.1038/s41368-020-0075-9 (2020);

17 Liu L et al. Epithelial cells lining salivary gland ducts are early target cells of severe acute respiratory syndrome coronavirus infection in the upper respiratory tracts of rhesus macaques. J. Virol. 85, 4025–4030 (2011);

18 Van Doremalen N, Bushmaker T, Morris DH et al. Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1. N Engl J Med. 2020 Mar 17. doi: 10.1056/NEJMc2004973, (2020);

19 Meng L, Hua F, Bian Z. Coronavirus Disease 2019 (COVID-19): Emerging and Future Challenges for Dental and Oral Medicine. First Published March 12, J Dent Res. 2020 Mar: [Epub ahead of print];

20 WHO, Rational use of personal protective equipment for coronavirus disease 2019 (COVID-19) and considerations during severe shortages Interim Guidance 6 April (2020);

21Yang Y, Soh HY, Cai ZG, Peng X, Zhang Y, Guo CB. Experience of Diagnosing and Managing Patients in Oral Maxillofacial Surgery during the Prevention and Control Period of the New Coronavirus Pneumonia. Chin J Dent Res 2020;23(1):57–62; doi: 10.3290/j.cjdr.a44339, (2020);

22 Center for Disease and Control of Infection (CDC), USA, 2020 https://www.cdc.gov/coronavirus/2019-ncov/hcp/dental-settings.html

23 Bartoszko JJ, Farooqi MAM, Alhazzani W, Loeb M. Medical Masks vs N95 Respirators for Preventing COVID-19 in Health Care Workers A

Page of 17 25

Systematic Review and Meta-Analysis of Randomized Trials. Influenza Other Respir Viruses. 2020 Apr 4. doi: 10.1111/irv.12745 (2020);

24 Ma QX, Shan H, Zhang HL, Li GM, Yang RM, Chen JM. Potential utilities of mask-wearing and instant hand hygiene for fighting SARS-CoV-2. J Med Virol. 2020 Mar 31. doi: 10.1002/jmv.25805 (2020);

25 Leung NH et al. Respiratory virus shedding in exhaled breath and efficacy of face masks. Nature Medicine 2020, epub 3 April 2020 https://doi.org/10.1038/s41591- 020-0843-2 (2020);

26 European Center for Disease and Control (ECDC) 2020. Technical Report Infection prevention and control and preparedness for COVID-19 in healthcare settings Second update 31 March 2020

27 Verbeek JH, Rajamaki B, Ijaz S, Sauni R, Toomey E, Blackwood B, Tikka C, Ruotsalainen JH, Kilinc Balci FS Personal protective equipment for preventing highly infectious diseases due to exposure to contaminated body fluids in healthcare staff.. Cochrane Database Syst Rev. 2020 Apr 15;4:CD011621. doi: 10.1002/14651858.CD011621.pub4.

28 Otter JA et al. Transmission of SARS and MERS coronaviruses and influenza virus in healthcare settings: the possible role of dry surface contamination. J. Hosp. Infect. 92, 235–250 (2016);

29 Nejatidanesh F, Khosravi Z, Goroohi H, et al. Risk of contamination of different areas of dentist’s face during dental practices. Int J Prev Med 2013;4:611–5;(2013);

30 Farooq I, Ali S. COVID-19 outbreak andits monetary implications for dental practices, hospitals and healthcareworkers. Postgrad Med J. 2020 Apr 3. pii: postgradmedj-2020-137781. doi:10.1136/postgradmedj-2020-137781 (2020);

31Ather A, Patel B, Ruparel NB, Diogenes A, Hargreaves KM. Coronavirus Disease 19 (COVID-19): Implications for Clinical Dental Care. J Endod. 2020 Apr 6. pii: S0099-2399(20)30159-X. doi: 10.1016/j.joen.2020.03.008;

Page of 18 25

32 EFP suggestions for the management of a dental clinic during the Covid-19 pandemic

33 Seto WH et al. Effectiveness of precautions against droplets and contact in prevention of nosocomial transmission of severe acute respiratory syndrome (SARS). Lancet 361, 1519–1520 (2003);

34 Samaranayake LP, Reid J, Evans D. The efficacy of rubber dam isolation in reducing atmospheric bacterial contamination. ASDC J Dent Child. 1989 Nov-Dec;56(6):442-4 (1989);

35 Liu Y et al; Aerodynamic Characteristics and RNA Concentration of SARS-CoV-2 Aerosol in Wuhan Hospitals during COVID-19 Outbreak; bioRxiv preprint doi: https://doi.org/10.1101/2020.03.08.982637.

36 Fong MW et al; Nonpharmaceutical Measures for Pandemic Influenza in Nonhealthcare Settings- Social Distancing Measures. Emerg Infect Dis 2020 May;26(5):976-984. doi:10.3201/eid2605.190995. Epub 2020 May 17. 37 Centers for Disease Control and Prevention (CDC). CDC Developing Guidance Regarding Responding to COVID-19 in Dental Settings. Division of Oral Health, National Center for Chronic Disease Prevention and Health Promotion; 2020; Available from: https://www.cdc.gov/oralhealth/infectioncontrol/statement-COVID.html.;

38 World Health Organization (WHO). Natural Ventilation for Infection Control in Health-Care Settings. James Atkinson, Yves Chartier, Carmen L.cia Pessoa-Silva, Paul Jensen, Yuguo Li, Wing-Hong Seto , editors. Geneva: World Health Organization; 2009. WHO Guidelines Approved by the Guidelines Review Committee.

39 https://www.cibse.org/knowledge/knowledge-items/detail?id=a0q20000008JuB7AAK

40 Henk Kranenberg, Daikin Europe NV 13/11/2018

Page of 19 25

8. Appendices - Procedures for Infection Prevention and control1

Page of 20 25

Page of 21 25

PPE should be donned and doffed in dedicated areas and in a systematic order that minimises the potential for cross contamination, especially when undertaking AGPs

The process for putting on donning and doffing PPE is critical to ensure its effectiveness.

Page of 22 25

Page of 23 25

There is no evidence that respirators add value over FRSMs for droplet protection

when both are used with recommended broader PPE measures in clinical care,

except in the context of AGPs. When used, FFP3 respirators must:

• be well fitted, covering both nose and mouth

• not be allowed to dangle around the neck of the wearer after or between each use

• not be touched once put on

• fit tested on all healthcare staff who may be required to wear an FFP3 respirator to

ensure an adequate seal/fit according to the manufacturers’ guidance

• fit checked (according to the manufacturers’ guidance) by staff every time an

FFP3 respirator is donned to ensure an adequate seal has been achieved

• compatible with other facial protection used i.e. protective eyewear so that this

does not interfere with the seal of the respiratory protection. Regular prescription

glasses are not considered adequate eye protection

• FFP3s should be removed outside the dental surgery where AGPs have been

generated in line with doffing protocol.

• disposed of and replaced if breathing becomes difficult, the respirator is damaged

or distorted, the respirator becomes obviously contaminated by respiratory

secretions or other body fluids, or if a proper face fit cannot be maintained. In

effect this means that FFP3s will be worn once for dental AGPs and then

discarded as clinical waste (hand hygiene must always be performed after

disposal)

Note that valved respirators are not fully fluid-resistant unless they are also

‘shrouded’. If a valved, non-shrouded FFP3 respirator is used then it should be

accompanied by full face protection for use in AGPs.

The HSE have stated that FFP2 and N95 respirators (filtering at least 94% and 95%

of airborne particles respectively) offer protection against COVID-19 and may be

used if FFP3 respirators are not available. Other respirators can be utilised by

individuals if they comply with HSE recommendations. Reusable respirators should

be cleaned according to the manufacturer’s instructions.

Page of 24 25

Uniforms

Uniforms should be transported home in a disposable plastic bag. This bag should

be disposed of into the household waste stream. They should be laundered:

• Separately from other household linen

• In a load not more than half the machine capacity

• At the maximum temperature the fabric can tolerate, then ironed or tumble-dried

Disposal

All single use or single session use PPE should be discarded as healthcare

(clinical) waste. Hand hygiene must always be performed after disposal. However,

re-usable eye and face protection is acceptable if decontaminated between single

or single sessional use, according to the manufacturer’s instructions or local

infection control policy.

Page of 25 25